241 related articles for article (PubMed ID: 3584470)
21. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
Hess B; Nakagawa Y; Coe FL
Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
[TBL] [Abstract][Full Text] [Related]
22. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
Hess B
Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
[TBL] [Abstract][Full Text] [Related]
23. Interaction between nephrocalcin and calcium oxalate monohydrate: a structural study.
Deganello S
Calcif Tissue Int; 1991 Jun; 48(6):421-8. PubMed ID: 2070277
[TBL] [Abstract][Full Text] [Related]
24. [New pathophysiologic aspects of nephrolithiasis].
Hess B
Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
[TBL] [Abstract][Full Text] [Related]
25. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.
Worcester EM; Sebastian JL; Hiatt JG; Beshensky AM; Sadowski JA
Calcif Tissue Int; 1993 Oct; 53(4):242-8. PubMed ID: 8275352
[TBL] [Abstract][Full Text] [Related]
26. Determination of protein-bound urinary gamma-carboxyglutamic acid in calcium nephrolithiasis.
Colette C; Benmbarek A; Boniface H; Astre C; Pares-Herbute N; Monnier L; Guitter J
Clin Chim Acta; 1991 Dec; 204(1-3):43-50. PubMed ID: 1819473
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of stone formation.
Worcester EM
Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
[TBL] [Abstract][Full Text] [Related]
28. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
29. Evidence that mouse renal proximal tubule cells produce nephrocalcin.
Sirivongs D; Nakagawa Y; Vishny WK; Favus MJ; Coe FL
Am J Physiol; 1989 Sep; 257(3 Pt 2):F390-8. PubMed ID: 2782421
[TBL] [Abstract][Full Text] [Related]
30. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.
Nakagawa Y; Parks JH; Kézdy FJ; Coe FL
Trans Assoc Am Physicians; 1985; 98():281-9. PubMed ID: 3842199
[No Abstract] [Full Text] [Related]
31. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo.
Nakagawa Y; Sirivongs D; Novy MB; Netzer MF; Michaels E; Vogelzang NJ; Coe FL
Cancer Res; 1992 Mar; 52(6):1573-9. PubMed ID: 1540966
[TBL] [Abstract][Full Text] [Related]
32. Defective urinary crystallization inhibition and urinary stone formation.
Carvalho M; Lulich JP; Osborne CA; Nakagawa Y
Int Braz J Urol; 2006; 32(3):342-8; discussion 349. PubMed ID: 16813682
[TBL] [Abstract][Full Text] [Related]
33. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
[TBL] [Abstract][Full Text] [Related]
34. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
Liu J; Chen J; Wang T; Wang S; Ye Z
J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
[TBL] [Abstract][Full Text] [Related]
35. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
Porile JL; Asplin JR; Parks JH; Nakagawa Y; Coe FL
J Am Soc Nephrol; 1996 Apr; 7(4):602-7. PubMed ID: 8724894
[TBL] [Abstract][Full Text] [Related]
36. A novel basic protein from human kidney which inhibits calcium oxalate crystal growth.
Selvam R; Kalaiselvi P
BJU Int; 2000 Jul; 86(1):7-13. PubMed ID: 10886075
[TBL] [Abstract][Full Text] [Related]
37. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
38. Urinary crystal surface binding substances on calcium oxalate crystals.
Koide T; Yoshioka T; Yamaguchi S; Hosokawa S; Utsunomiya M; Sonoda T
Urol Res; 1990; 18(6):387-92. PubMed ID: 2100413
[TBL] [Abstract][Full Text] [Related]
39. The reappraisal of nephrocalcin--its role in the inhibition of calcium oxalate crystal growth and interaction with divalent metal ions.
Chang LC; Lin HS; Chen WC
Urol Res; 2001 Apr; 29(2):89-93. PubMed ID: 11396734
[TBL] [Abstract][Full Text] [Related]
40. Kidney stone inhibitors in patients with renal stones and endemic renal tubular acidosis in northeast Thailand.
Nakagawa Y; Carvalho M; Malasit P; Nimmannit S; Sritippaywan S; Vasuvattakul S; Chutipongtanate S; Chaowagul V; Nilwarangkur S
Urol Res; 2004 May; 32(2):112-6. PubMed ID: 14758448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
